Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in drug makers

Lupin Launches Generic Antifungal Product In US Market

Tavaborole Topical Solution is generic equivalent of Anacor Pharmaceuticals' Kerydin Topical Solution and is an oxaborole antifungal indicated for the topical treatment of onychomycosis of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes.

Read More

Dr Reddy's Expects Biz Growth To Be Volatile In Current Fiscal

Higher productivity is also enabled by scaling up of robotic process automation (RPAs) as well as digitalised processes with automated incident tracking and near zero manual errors

Read More

Sun Pharma, Alembic Recall Products In The US Market

Princeton (New Jersey) based Sun Pharmaceutical Industries Inc is also recalling 2,520 bottles of diabetes drug, Metformin HCl Extended-Release tablets, in the US market.

Read More

OxyContin Maker Purdue Nears Guilty Plea Agreement In US Criminal Probe

Certain family members are in discussions to pay a roughly $225 million civil penalty for allegedly causing false claims regarding Purdue's prescription painkillers to be filed with government healthcare programs

Read More

Takeda India Donates Rs 1.2 Cr To PM CARES Fund

The contribution to the Fund aims to support patients and the government to contain the spread of the disease, the company said in a statement.

Read More

Sun Pharma To Conduct Clinical Trial Of Pancreatitis Drug In COVID-19 Patients

The University of Tokyo had announced plans for a trial of nafamostat and camostat mesilate, a related drug, starting as early as April 2020.

Read More

Drugmaker Sanofi To Raise Over $11 Billion Via Sale Of Regeneron Shares

Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.

Read More

Pharma: Shrinking Fortunes

Billionaire drug makers in India are experiencing a drop in revenue, largely due to tough market conditions in the US

Read More

BP, Cardiac Drug In Short Supply

Drug makers blame price controls over the short supply of the drug. Mankind Pharmaceuticals stopped manufacturing the drug as soon as the price control was announced. The company says they paid taxes out of their own pocket due to nonviable costing

Read More

Sun Pharma Buys Russian Drug Maker JSC Biosintez

JSC is currently engaged in manufacture and marketing of pharmaceutical products in Russia and CIS region mainly focusing on the hospital segment had annual revenues of approximately $ 52 million in 2015

Read More

Playing Cat And Mouse

This situation is unique to India, where sales growth of companies is closely connected to brand launches

Read More